Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2000
08/31/2000WO2000050566A2 Genes encoding insect odorant receptors and uses thereof
08/31/2000WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050457A1 Prostate-specific membrane antigens and methods of making and using
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050445A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
08/31/2000WO2000050066A1 Treatment of infertility
08/31/2000WO2000050065A1 Treatment of infertility
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000050061A1 Detecting the expression of the desc1 gene in squamous cell carcinoma
08/31/2000WO2000050049A2 Artificial salivary gland
08/31/2000WO2000050048A2 Bone marrow transplantation for hepatic regeneration and repair
08/31/2000WO2000049862A1 Transgenic mollusc and method for constructing the same
08/31/2000WO2000036113A3 Extending graft survival by heme oxygenase-i expression induced immunomodulation
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000026390A3 Genes and vectors for conferring herbicide resistance in plants
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000023472A3 Interferon-beta fusion proteins and uses
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000023112A9 Modulation of gene expression by combination therapy
08/31/2000WO2000020601A9 Polyketide synthase enzymes and recombinant dna constructs therefor
08/31/2000WO2000018932A9 Receptor based antagonists and methods of making and using
08/31/2000WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor
08/31/2000WO2000018914A3 Novel dkr polypeptides
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses
08/31/2000WO2000015768A9 Immune activation by double-stranded polynucleotides
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2365019A1 Novel polypeptide
08/31/2000CA2364966A1 Genes encoding insect odorant receptors and uses thereof
08/31/2000CA2363794A1 14273 receptor, a novel g-protein coupled receptor
08/31/2000CA2363704A1 Expressing gp140 fragment of primary hiv-1 isolate
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000CA2363106A1 Mdm interacting protein and methods of use thereof
08/31/2000CA2363074A1 Treatment of infertility
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362585A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage
08/31/2000CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
08/31/2000CA2361401A1 Transplantation of haematopoietic cells
08/31/2000CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/30/2000EP1031835A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases.
08/30/2000EP1031627A1 Beta-carotene 15,15'-dioxygenase
08/30/2000EP1030929A1 Transfection and transfer of male germ cells for generation of transgenic species
08/30/2000EP1030928A1 Development of viruses resistant to inactivation by the human complement system
08/30/2000EP1030926A2 Transgenic models of inflammatory disease
08/30/2000EP1030925A1 The translation enhancer element of the human amyloid precursor protein gene
08/30/2000EP1030924A1 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same
08/30/2000EP1030922A1 $i(dull1) CODING FOR A STARCH SYNTHASE AND USES THEREOF
08/30/2000EP1030919A2 Cdk2 protein and cdk2 protein complexes
08/30/2000EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/30/2000EP1030913A2 Nucleic acid catalysts with endonuclease activity
08/30/2000EP1030911A1 Human aspartic proteases
08/30/2000EP1030909A1 Immune activation by double-stranded polynucleotides
08/30/2000EP1030908A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
08/30/2000EP1030867A1 Mammalian milk growth factor
08/30/2000EP1030865A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
08/30/2000EP1030860A1 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain
08/30/2000EP1030859A1 Ras-binding protein (pre1)
08/30/2000EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport
08/30/2000EP1030697A2 Biodegradable polymer scaffold
08/30/2000EP1030685A2 Essential bacterial genes and their use
08/30/2000EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
08/30/2000EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
08/30/2000EP1030676A1 Bonding of cartilaginous matrices using isolated chondrocytes
08/30/2000EP1030675A2 Treatment of hematologic disorders
08/30/2000EP1030674A1 METHODS FOR TREATMENT OF TUMORS AND TUMOR CELLS USING $i(EX VIVO) ACTIVATED T CELLS
08/30/2000EP1006783A4 Shoot meristem specific promoter sequences
08/30/2000EP0831876A4 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
08/30/2000EP0671946B1 Immunoreactive peptides from epstein-barr virus
08/30/2000EP0527199B2 Compositions for use in a method for treating a human suffering from multiple sclerosis
08/30/2000EP0248819B2 Recombinant fibroblast growth factors
08/30/2000CN1265152A Prodn. of human mutant, proteins in human cells by homologous recombination
08/30/2000CN1265151A Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop prodn.
08/30/2000CN1265150A Genetic method for controlling sprouting
08/30/2000CN1265149A Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
08/30/2000CN1265148A Anticoagulant fusion protein anchored to cell membrane
08/30/2000CN1265147A Method for producing biotin
08/30/2000CN1265145A Hypersensitive response elicitor fragments and uses thereof
08/30/2000CN1265144A Identification of human cell lines for prodn. of human proteins by endogenous gene activation
08/30/2000CN1265143A Prodn. of erythropoietin by endogenous gene activation
08/30/2000CN1265038A Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation
08/29/2000USRE36844 Cellular attachment to trans-epithelial appliances
08/29/2000US6111165 Production of human recombinant collagen in the milk of transgenic animals
08/29/2000US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators
08/29/2000US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent
08/29/2000US6111081 Lactoferrin variants and uses thereof
08/29/2000US6111080 Hybridoma cell line like b6h12, atcc hb 9771; produces antibodies which recognize integrin receptor that binds to proteins containing amino acid sequence arginine-glycine-aspartic acid; suppresses phagocytosis enhancement
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6111070 Polypeptides encoded by octopine T-DNA open reading frames
08/29/2000US6111066 Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
08/29/2000US6110916 For transfection/drug delivery of macromolecules and other compounds into cells
08/29/2000US6110744 Diminishing viral gene expression by promoter replacement
08/29/2000US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients
08/29/2000US6110741 Gonadotrophin releasor hormone-containing composition for embryo culture and method for in vitro fertilization
08/29/2000US6110740 Human vault RNA
08/29/2000US6110739 Producing immortalized cell population by transforming embryonic stem cell population with immortalizing gene, culturing, incubating to obtain cell population that differentiates into primitive and definitive erythroid cells
08/29/2000US6110737 Nucleotide sequence; enhancing response of cells; determining regions involved in signal transduction; drug screening; for mutants; anticarcinogenic agents; wound healing agents; antiproliferative agents; prevention of atherosclerosis
1 ... 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 ... 1827